Trade Mark Journal No.2026/043 23 October 2026

UK00004457577 9 October 2026 (5)

MYPLENCIA

Class 5: Pharmaceutical preparations and products; pharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurological and metabolic diseases and disorders; pharmaceutical preparations for the prevention and treatment of cellular abnormalities; pharmaceutical preparations for improving muscle strength and muscle function.

Atnahs Pharma UK Limited

Representative: Venner Shipley LLP